EUDA Health Holdings Warrant
EUDAW
9 hedge funds and large institutions have $23.9K invested in EUDA Health Holdings Warrant in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 6 → 9 (+3)
73% less capital invested
Capital invested by funds: $88K → $23.9K (-$64.1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.67K |
| 2 |
CS
Clear Street
New York
|
+$15 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$683 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$26 |
EUDAW Hedge Fund Activity: Q1 2026 in Review
9 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q1 2026, worth a combined $23.9K — down 73% from $88K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EUDAW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.67K. The largest seller was AQR Arbitrage, cutting an estimated $683.
- 9 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q1 2026, up from 6 in Q4 2025.
- Funds reported $23.9K of EUDA Health Holdings Warrant stock for Q1 2026, down 73% quarter-over-quarter.
- 3 funds opened new EUDA Health Holdings Warrant positions in Q1 2026 and 0 closed out, a net change of +3 holders.
- The largest EUDA Health Holdings Warrant buyer in Q1 2026 was Susquehanna International Group, an estimated $2.67K added.
- The largest EUDA Health Holdings Warrant seller in Q1 2026 was AQR Arbitrage, an estimated $683 sold.
Based on aggregated 13F filings for Q1 2026.